CD2AP loss association with cognitive decline in AD patients

Exploratory Score: 0.850 Price: $0.50 Alzheimer's disease human patients Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting CD2AP in human patients. Primary outcome: association between vascular CD2AP loss and cognitive decline

Description

Analysis of CD2AP expression in cerebral blood vessels from Alzheimer's disease patients to determine correlation with cognitive decline. This human pathological study examined post-mortem brain tissue from AD subjects to assess whether loss of CD2AP in brain vasculature is associated with cognitive impairment. The study likely used immunohistochemistry or similar techniques to quantify CD2AP protein levels in cerebral blood vessels and correlated these findings with clinical measures of cognitive function obtained prior to death.

TARGET GENE
CD2AP
MODEL SYSTEM
human patients
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
cerebrovascular function
SOURCE
extracted_from_pmid_39892386
PRIMARY OUTCOME
association between vascular CD2AP loss and cognitive decline

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

CD2AP ProteinproteinCD2AP Synaptic Dysfunction Alzheimer's Disease CaumechanismCD2AP Gene — CD2-Associated ProteingeneTREM2 Variants in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseasePSEN2 Mutations in Alzheimer's DiseasediseasePSEN1 Mutations in Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseInvestment Landscape: Alzheimer's DiseasediseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseAPP Mutations in Alzheimer's DiseasediseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAlzheimer's Disease Genetic Variantsdisease

Protocol

post-mortem brain tissue analysis with correlation to cognitive assessments

Expected Outcomes

reduced CD2AP in cerebral vessels correlates with cognitive decline

Success Criteria

significant correlation between CD2AP loss and cognitive impairment

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.